Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SMS PHARMA Gains 3%; BSE HEALTHCARE Index Up 0.2%
Fri, 2 Aug 10:44

SMS PHARMA Gains 3%; BSE HEALTHCARE Index Up 0.2%Image source: Ivcandy/www.istockphoto.com

SMS PHARMA share price has zoomed 3% and is presently trading at Rs 312.5.

Meanwhile, the BSE HEALTHCARE index is at 40,729.9 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are GSK Pharma (up 2.4%) and GRANULES INDIA (up 2.1%).

Jubilant Pharmova (down 2.1%) and MAX HEALTHCARE INSTITUTE (down 1.5%) are among the top losers today.

Over the last one year, SMS PHARMA has moved up from Rs 118.1 to Rs 312.5, registering a gain of Rs 194.4 (up 164.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,729.9, registering a gain of 46.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 124.8%), GSK Pharma (up 101.9%) and SUVEN PHARMACEUTICALS (up 99.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,204.2 (down 0.8%).

The top losers among the BSE Sensex today are Tata Motors (down 3.9%) and Maruti Suzuki (down 3.6%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,803.7 (down 0.8%). Tata Motors and Maruti Suzuki are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,204.2, registering a gain of 14,676.5 points (up 22.1%).

SMS PHARMA Financial Update...

SMS PHARMA net profit grew 99.0% YoY to Rs 161 million for the quarter ended March 2024, compared to a profit of Rs 81 million a year ago. Net sales rose 64.5% to Rs 2,458 million during the period as against Rs 1,494 million in January-March 2023.

For the year ended March 2023, SMS PHARMA reported 94.3% decrease in net profit to Rs 39 million compared to net profit of Rs 679 million during FY22. Revenue of the company grew 1.2% to Rs 4,914 million during FY23.

The current Price to earnings ratio of SMS PHARMA, based on rolling 12 month earnings, stands at 53.8.


Equitymaster requests your view! Post a comment on "SMS PHARMA Gains 3%; BSE HEALTHCARE Index Up 0.2%". Click here!